The Leukemia & Lymphoma Society of Canada

The mission of The Leukemia & Lymphoma Society of Canada (LLSC) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2018, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.2 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.6 million towards funding patient services, programs and education across Canada.

We do not charge patients, caregivers or healthcare professionals anything for any of the programs or materials we provide to them, but everything we do has costs associated with it. We do our best to minimize costs, while still ensuring the quality of the program or resource.